Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Navarro

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Frontiers in Pharmacology|June 18, 2026
Early biomarkers associated with prenatal alcohol exposure and neurodevelopmental outcomesIsabel Ochando, Angela Sempere, Daniela Navarro
Frontiers in Endocrinology|September 25, 2014
An evo-devo approach to thyroid hormones in cerebral and cerebellar cortical development: etiological implications for autismPere Berbel, Daniela Navarro, Gustavo C Román
Neuropharmacology|April 21, 2023
Cannabidiol regulates behavioral and brain alterations induced by spontaneous alcohol withdrawalAni Gasparyan, Francisco Navarrete, Daniela Navarro, et al.
Neuropharmacology|August 16, 2022
Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studiesAni Gasparyan, Daniela Navarro, Francisco Navarrete, et al.
International Journal of Molecular Sciences|July 13, 2024
Fetal Cannabinoid Syndrome: Behavioral and Brain Alterations of the Offspring Exposed to Dronabinol during Gestation and LactationDaniela Navarro, Ani Gasparyan, Francisco Navarrete, et al.
Frontiers in Pharmacology|May 5, 2023
Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress modelMaría Salud García-Gutiérrez, Daniela Navarro, Amaya Austrich-Olivares, et al.
Biomolecules|November 27, 2021
CB2 Receptor Involvement in the Treatment of Substance Use DisordersFrancisco Navarrete, María S García-Gutiérrez, Ani Gasparyan, et al.
Acta Ortopedica Brasileira|April 9, 2016
Influence of nitric oxide in the improvement of muscle powerDaniela Navarro D'Almeida Bernardo, Flávio Fernandes Bryk, Patrícia Maria de Moraes Barros Fucs
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2025
MCH11, a new monoacylglycerol lipase inhibitor, reduces ethanol consumption and motivation to drink in mice, with sex-dependent differencesAbraham B Torregrosa, María S García-Gutiérrez, Daniela Navarro, et al.
Pharmacological Research|February 20, 2025
A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disordersMaría S García-Gutiérrez, Abraham B Torregrosa, Francisco Navarrete, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|June 18, 2026
Early biomarkers associated with prenatal alcohol exposure and neurodevelopmental outcomesIsabel Ochando, Angela Sempere, Daniela Navarro
Frontiers in Endocrinology|September 25, 2014
An evo-devo approach to thyroid hormones in cerebral and cerebellar cortical development: etiological implications for autismPere Berbel, Daniela Navarro, Gustavo C Román
Neuropharmacology|April 21, 2023
Cannabidiol regulates behavioral and brain alterations induced by spontaneous alcohol withdrawalAni Gasparyan, Francisco Navarrete, Daniela Navarro, et al.
Neuropharmacology|August 16, 2022
Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studiesAni Gasparyan, Daniela Navarro, Francisco Navarrete, et al.
International Journal of Molecular Sciences|July 13, 2024
Fetal Cannabinoid Syndrome: Behavioral and Brain Alterations of the Offspring Exposed to Dronabinol during Gestation and LactationDaniela Navarro, Ani Gasparyan, Francisco Navarrete, et al.
Frontiers in Pharmacology|May 5, 2023
Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress modelMaría Salud García-Gutiérrez, Daniela Navarro, Amaya Austrich-Olivares, et al.
Biomolecules|November 27, 2021
CB2 Receptor Involvement in the Treatment of Substance Use DisordersFrancisco Navarrete, María S García-Gutiérrez, Ani Gasparyan, et al.
Acta Ortopedica Brasileira|April 9, 2016
Influence of nitric oxide in the improvement of muscle powerDaniela Navarro D'Almeida Bernardo, Flávio Fernandes Bryk, Patrícia Maria de Moraes Barros Fucs
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2025
MCH11, a new monoacylglycerol lipase inhibitor, reduces ethanol consumption and motivation to drink in mice, with sex-dependent differencesAbraham B Torregrosa, María S García-Gutiérrez, Daniela Navarro, et al.
Pharmacological Research|February 20, 2025
A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disordersMaría S García-Gutiérrez, Abraham B Torregrosa, Francisco Navarrete, et al.
Pageof 4